Efficacy and safety of pregabalin in alcohol dependence

被引:40
作者
Martinotti, Giovanni [1 ]
Di Nicola, Marco [1 ]
Tedeschi, Daniela [1 ]
Mazza, Marianna [1 ]
Janiri, Luigi [1 ]
Bria, Pietro [1 ]
机构
[1] Catholic Univ, Sch Med, Dept Psychiat, Rome, Italy
关键词
alcohol dependence; anticonvulsants; calcium channels; craving; pregabalin;
D O I
10.1007/s12325-008-0066-2
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Introduction: Pregabalin is a new anxiolytic that selectively binds to the alpha2-delta subunit of voltage-gated calcium channels, inhibiting release of excessive levels of excitatory neurotransmitters. In this open-label trial we aimed to investigate the efficacy of pregabalin on alcoholism indices in detoxified alcohol-dependent subjects. Reduction of cravings, psychiatric symptom improvements, and the evaluation of safety parameters were the secondary endpoints. Methods: Thirty-one alcohol-dependent patients were consecutively recruited and screened for the study. Twenty detoxified patients received pregabalin starting at 50 mg/day (orally) in the first week, gradually increasing to a flexible dose of 150-450 mg/day. Subjects were assessed at the beginning of the treatment, and after 2, 8 and 16 weeks. Craving (visual analogue scale, Obsessive and Compulsive Drinking Scale [OCDS]) and withdrawal (Clinical Institute Withdrawal Assessment for Alcohol [CIWA-Ar]) rating scales were applied; psychiatric symptoms were evaluated through the Symptom Check List-90-Revised (SCL-90-R). Results: Out of the twenty patients who received the study drug, 15 completed the study procedures: 10 remained totally alcohol-free for the duration of the study, five relapsed. An additional four patients dropped out during the study, and one stopped taking medication due to adverse events. A significant progressive reduction of both craving and withdrawal symptomatology were observed. Safety parameters did not show any significant variation during treatment. Conclusion: Pregabalin shows promise as a treatment for alcohol dependence. Although limited by a low number of participants and by the open design, this is the first study concerning the efficacy and safety of pregabalin in current alcoholics. In these patients pregabalin was effective and well tolerated. Additional research is needed to explore the clinical relevance of these findings.
引用
收藏
页码:608 / 618
页数:11
相关论文
共 42 条
[1]   Baclofen: a new drug for the treatment of alcohol dependence [J].
Addolorato, G. ;
Leggio, L. ;
Agabio, R. ;
Colombo, G. ;
Gasbarrini, G. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (08) :1003-1008
[2]   An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants [J].
Ait-Daoud, Nassima ;
Malcolm, Robert J., Jr. ;
Johnson, Bankole A. .
ADDICTIVE BEHAVIORS, 2006, 31 (09) :1628-1649
[3]  
[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[4]   Pregabalin add-on treatment: A randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures [J].
Arroyo, S ;
Anhut, H ;
Kugler, AR ;
Lee, CM ;
Knapp, LE ;
Garofalo, EA ;
Messmer, S .
EPILEPSIA, 2004, 45 (01) :20-27
[5]   Pregabalin is effective against behavioral and electrographic seizures during alcohol withdrawal [J].
Becker, Howard C. ;
Myrick, Hugh ;
Veatch, Lynn M. .
ALCOHOL AND ALCOHOLISM, 2006, 41 (04) :399-406
[6]   Novel anticonvulsants in the treatment of alcoholism [J].
Book, SW ;
Myrick, H .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (04) :371-376
[7]  
Bryans JS, 1999, MED RES REV, V19, P149, DOI 10.1002/(SICI)1098-1128(199903)19:2<149::AID-MED3>3.0.CO
[8]  
2-B
[9]   Patients with schizophrenia treated with aripiprazole, a multicentre naturalistic study [J].
Christensen, AF ;
Poulsen, J ;
Nielsen, CT ;
Bork, B ;
Christensen, A ;
Christensen, M .
ACTA PSYCHIATRICA SCANDINAVICA, 2006, 113 (02) :148-153
[10]   Pregabalin for the treatment of fibromyalgia syndrome - Results of a randomized, double-blind, placebo-controlled trial [J].
Crofford, LJ ;
Rowbotham, MC ;
Mease, PJ ;
Russell, IJ ;
Dworkin, RH ;
Corbin, AE ;
Young, JP ;
LaMoreaux, LK ;
Martin, SA ;
Sharma, U .
ARTHRITIS AND RHEUMATISM, 2005, 52 (04) :1264-1273